Lang Li

6.8k total citations
158 papers, 5.1k citations indexed

About

Lang Li is a scholar working on Molecular Biology, Oncology and Genetics. According to data from OpenAlex, Lang Li has authored 158 papers receiving a total of 5.1k indexed citations (citations by other indexed papers that have themselves been cited), including 82 papers in Molecular Biology, 33 papers in Oncology and 27 papers in Genetics. Recurrent topics in Lang Li's work include Pharmacogenetics and Drug Metabolism (26 papers), Computational Drug Discovery Methods (25 papers) and Estrogen and related hormone effects (18 papers). Lang Li is often cited by papers focused on Pharmacogenetics and Drug Metabolism (26 papers), Computational Drug Discovery Methods (25 papers) and Estrogen and related hormone effects (18 papers). Lang Li collaborates with scholars based in United States, China and United Kingdom. Lang Li's co-authors include David A. Flockhart, John N. Eble, Stephen D. Hall, Michael O. Koch, Liang Cheng, Zeruesenay Desta, Todd C. Skaar, Anne Nguyen, Thomas M. Ulbright and Anna Maria Storniolo and has published in prestigious journals such as Journal of Biological Chemistry, Journal of Clinical Oncology and Blood.

In The Last Decade

Lang Li

154 papers receiving 5.0k citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Lang Li United States 39 2.0k 1.4k 642 622 604 158 5.1k
Gillian Smith United Kingdom 44 2.1k 1.1× 1.5k 1.1× 1.1k 1.7× 664 1.1× 447 0.7× 127 7.1k
Michael J. Sorich Australia 38 1.8k 0.9× 2.1k 1.5× 779 1.2× 480 0.8× 813 1.3× 205 5.7k
Ross A. McKinnon Australia 44 2.3k 1.1× 2.0k 1.5× 1.8k 2.7× 858 1.4× 577 1.0× 224 6.3k
Gregory D. Jenkins United States 37 1.9k 0.9× 802 0.6× 356 0.6× 543 0.9× 836 1.4× 127 4.6k
Cristina Rodríguez‐Antona Spain 39 2.2k 1.1× 2.1k 1.5× 2.0k 3.0× 1.1k 1.8× 767 1.3× 137 6.0k
Hui Quan United States 32 1.3k 0.7× 1.9k 1.4× 501 0.8× 319 0.5× 384 0.6× 111 8.2k
Taisei Mushiroda Japan 40 1.2k 0.6× 1.0k 0.8× 1.5k 2.4× 379 0.6× 325 0.5× 147 5.1k
Balram Chowbay Singapore 37 1.4k 0.7× 1.7k 1.3× 1.3k 2.1× 436 0.7× 514 0.9× 109 4.2k
Toshiyuki Sakaeda Japan 45 2.1k 1.0× 2.8k 2.1× 974 1.5× 312 0.5× 537 0.9× 220 7.1k
Yoshiro Saito Japan 45 2.3k 1.1× 2.2k 1.6× 1.9k 2.9× 426 0.7× 441 0.7× 257 6.5k

Countries citing papers authored by Lang Li

Since Specialization
Citations

This map shows the geographic impact of Lang Li's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Lang Li with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Lang Li more than expected).

Fields of papers citing papers by Lang Li

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Lang Li. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Lang Li. The network helps show where Lang Li may publish in the future.

Co-authorship network of co-authors of Lang Li

This figure shows the co-authorship network connecting the top 25 collaborators of Lang Li. A scholar is included among the top collaborators of Lang Li based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Lang Li. Lang Li is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
2.
Wu, Heng‐Yi, Sara K. Quinney, Shijun Zhang, et al.. (2022). PhenoDEF: a corpus for annotating sentences with information of phenotype definitions in biomedical literature. Journal of Biomedical Semantics. 13(1). 17–17. 5 indexed citations
3.
Wu, Heng‐Yi, Lei Wang, Gongbo Zhang, et al.. (2022). Translational drug–interaction corpus. Database. 2022. 4 indexed citations
4.
Skiles, Jodi, Chien‐Wei Chiang, Ellen L. Smith, et al.. (2018). CYP3A5 genotype and its impact on vincristine pharmacokinetics and development of neuropathy in Kenyan children with cancer. PMC. 5 indexed citations
5.
Alam, Khondoker, Alexandra Crowe, Pengyue Zhang, et al.. (2018). Regulation of Organic Anion Transporting Polypeptides (OATP) 1B1- and OATP1B3-Mediated Transport: An Updated Review in the Context of OATP-Mediated Drug-Drug Interactions. PMC.
6.
Wang, Weili, Lei Huang, Jian‐Yue Jin, et al.. (2018). IDO Immune Status after Chemoradiation May Predict Survival in Lung Cancer Patients. PMC. 1 indexed citations
7.
Anjanappa, Manjushree, Angelo A. Cardoso, Lijun Cheng, et al.. (2017). Individualized Breast Cancer Characterization through Single-Cell Analysis of Tumor and Adjacent Normal Cells. Cancer Research. 77(10). 2759–2769. 16 indexed citations
8.
Wang, Weili, Lei Huang, Jian‐Yue Jin, et al.. (2017). IDO Immune Status after Chemoradiation May Predict Survival in Lung Cancer Patients. Cancer Research. 78(3). 809–816. 54 indexed citations
9.
Han, Xu, Charles E. Leonard, Warren B. Bilker, et al.. (2017). Biomedical Informatics Approaches to Identifying Drug–Drug Interactions. Epidemiology. 28(3). 459–468. 19 indexed citations
10.
Schneider, Bryan P., Fei Shen, Laura Gardner, et al.. (2016). Genome-Wide Association Study for Anthracycline-Induced Congestive Heart Failure. Clinical Cancer Research. 23(1). 43–51. 66 indexed citations
11.
Duchnowska, Renata, Jacek Jassem, Chirayu Goswami, et al.. (2015). Predicting early brain metastases based on clinicopathological factors and gene expression analysis in advanced HER2-positive breast cancer patients. Journal of Neuro-Oncology. 122(1). 205–216. 29 indexed citations
12.
Gökmen‐Polar, Yesim, Chirayu Goswami, Rachel A. Toroni, et al.. (2014). Gene Expression Analysis Reveals Distinct Pathways of Resistance to Bevacizumab in Xenograft Models of Human ER-Positive Breast Cancer. Publisher. 2 indexed citations
13.
Schneider, Bryan P., Robert J. Gray, Milan Radovich, et al.. (2013). Prognostic and Predictive Value of Tumor Vascular Endothelial Growth Factor Gene Amplification in Metastatic Breast Cancer Treated with Paclitaxel with and without Bevacizumab; Results from ECOG 2100 Trial. Clinical Cancer Research. 19(5). 1281–1289. 47 indexed citations
14.
Peng, Xiaodong, Fang Wang, Liwei Li, et al.. (2013). Exploring a structural protein–drug interactome for new therapeutics in lung cancer. Molecular BioSystems. 10(3). 581–591. 12 indexed citations
15.
Jiang, Guanglong, Arindom Chakraborty, Zhiping Wang, et al.. (2013). New aQTL SNPs for the CYP2D6 Identified by a Novel Mediation Analysis of Genome-Wide SNP Arrays, Gene Expression Arrays, and CYP2D6 Activity. BioMed Research International. 2013. 1–7. 8 indexed citations
16.
Henry, N. Lynn, Faouzi Azzouz, Zereunesay Desta, et al.. (2012). Predictors of Aromatase Inhibitor Discontinuation as a Result of Treatment-Emergent Symptoms in Early-Stage Breast Cancer. Journal of Clinical Oncology. 30(9). 936–942. 284 indexed citations
17.
Kitchens, John W., Nawal Kassem, William J. Wood, et al.. (2011). A Pilot Study of Pharmacogenetics as a Predictor of Outcome in Patients Receiving Intravitreal Anti-VEGF Therapy in Age Related Macular Degeneration (AMD). Investigative Ophthalmology & Visual Science. 52(14). 5259–5259. 2 indexed citations
18.
Fang, Fang, Curt Balch, Jeanne M. Schilder, et al.. (2010). A phase 1 and pharmacodynamic study of decitabine in combination with carboplatin in patients with recurrent, platinum‐resistant, epithelial ovarian cancer. Cancer. 116(17). 4043–4053. 139 indexed citations
19.
Li, Lang & Siu Hui. (2007). Positive False Discovery Rate Estimate in Step-Wise Variable Selection. Communications in Statistics - Simulation and Computation. 36(6). 1217–1231. 3 indexed citations
20.
Wei, Susan, Curtis Balch, Henry Paik, et al.. (2006). Prognostic DNA Methylation Biomarkers in Ovarian Cancer. Clinical Cancer Research. 12(9). 2788–2794. 118 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026